<DOC>
	<DOCNO>NCT01941901</DOCNO>
	<brief_summary>The purpose study evaluate effect calcium electroporation cutaneous metastasis , compare calcium electroporation standard treatment : electrochemotherapy .</brief_summary>
	<brief_title>Calcium Electroporation Treatment Cutaneous Metastases</brief_title>
	<detailed_description>Double-blinded phase II clinical study . We compare effect calcium electroporation treatment cutaneous metastasis standard treatment : electrochemotherapy intratumoral injection bleomycin . Separate randomisation perform lesion treat either intratumoral injection calcium bleomycin . It treatment patient follow 6 month . It non-inferiority study accept difference response 15 % .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Age &gt; 18 year . Histological confirm cutaneous metastasis histology . At least 1. cutaneous metastasis 0,5 3cm , available electroporation . Patient offer standard treatment . At least 2 week since chemotherapy radiotherapy . Performance status &gt; 2 ( ECOG ) . Life expectancy &gt; 3 month . platelet count &gt; 50 mia/l . International Normalized Ratio ( INR ) &lt; 1,2 . Men woman reproductive age must use effective contraception study . Patient able understand participant information . Signed , informed consent . Previously treatment bleomycin &gt; 200.000 Units/m2 . Allergy bleomycin . Clinically significant coagulopathy . Pregnancy lactation . Participation clinical trial involve experimental drug participation clinical trial within 4 week study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Cutaneous metastasis</keyword>
</DOC>